{"title":"[Polymyositis and systemic sclerosis overlap - A case report and a review of the literature].","authors":"Marin Petrić, Dušanka Martinović Kaliterna, Ivona Božić, Marija Nuić, Dijana Perković","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Polymyositis (PM) is an autoimmune disease which affects skeletal muscles. In young age, it usually\noccurs as an idiopathic disorder associated with specific autoantibodies (anti-Jo), while in older age it is often associated\nwith neoplasms. It can present with symptoms of other autoimmune diseases, such as systemic sclerosis (SSc), a\nrare progressive disease characterized by collagen deposits in various tissues and organs.\nA 65-year-old patient, long-time smoker, came to the ER because of painful edema in the distal parts of his limbs\nand proximal muscle weakness of his arms and legs. Although his muscle enzymes were not increased, PM was confirmed\nby the characteristic pathohistological finding. The patient had sclerodermal skin lesions on his back, but he did\nnot have other typical SSc symptoms, and the specific autoantibodies were negative. He received glucocorticoid therapy\n(GC) after we had finished screening for malignant tumors. He felt better, his muscle strength returned, and the\nlimb edema disappeared. Four weeks later, he developed symptoms which are more typical of SSc, such as dysphagia,\nRaynaud’s phenomenon, and skin thickening of the limbs that had been swollen.\nPM is often associated with SSc. It is not clear if the exacerbation of latent SSc was stimulated by GC, or if it was\njust a simple overlap of the two diseases with different onsets. There are no therapy guidelines for the treatment of this\ncombination of diseases. Careful use of GC is necessary even if SSc symptoms are discreet, because of the well-known\neffects of GC in SSc.</p>","PeriodicalId":76426,"journal":{"name":"Reumatizam","volume":"63 1","pages":"10-3"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reumatizam","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Polymyositis (PM) is an autoimmune disease which affects skeletal muscles. In young age, it usually
occurs as an idiopathic disorder associated with specific autoantibodies (anti-Jo), while in older age it is often associated
with neoplasms. It can present with symptoms of other autoimmune diseases, such as systemic sclerosis (SSc), a
rare progressive disease characterized by collagen deposits in various tissues and organs.
A 65-year-old patient, long-time smoker, came to the ER because of painful edema in the distal parts of his limbs
and proximal muscle weakness of his arms and legs. Although his muscle enzymes were not increased, PM was confirmed
by the characteristic pathohistological finding. The patient had sclerodermal skin lesions on his back, but he did
not have other typical SSc symptoms, and the specific autoantibodies were negative. He received glucocorticoid therapy
(GC) after we had finished screening for malignant tumors. He felt better, his muscle strength returned, and the
limb edema disappeared. Four weeks later, he developed symptoms which are more typical of SSc, such as dysphagia,
Raynaud’s phenomenon, and skin thickening of the limbs that had been swollen.
PM is often associated with SSc. It is not clear if the exacerbation of latent SSc was stimulated by GC, or if it was
just a simple overlap of the two diseases with different onsets. There are no therapy guidelines for the treatment of this
combination of diseases. Careful use of GC is necessary even if SSc symptoms are discreet, because of the well-known
effects of GC in SSc.